The Role of Interleukin-6 and Interleukin-8 Circulating Cytokines in Differentiating between Feeding Intolerance and Necrotizing Enterocolitis in Preterm Infants

Abhay Lodha; Alexandra Howlett; Talat Ahmed; Aideen M. Moore

doi:10.1055/s-0037-1603329

American Journal of Perinatology, Table of Contents

Am J Perinatol 2017; 34(13): 1286-1292
DOI: 10.1055/s-0037-1603329

Original Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Role of Interleukin-6 and Interleukin-8 Circulating Cytokines in Differentiating between Feeding Intolerance and Necrotizing Enterocolitis in Preterm Infants

Abhay Lodha

¹Division of Neonatology, Department of Pediatrics, University of Calgary, Calgary, Canada

²Alberta Children's Hospital Research Institute, Calgary, Canada

,

Alexandra Howlett

¹Division of Neonatology, Department of Pediatrics, University of Calgary, Calgary, Canada

,

Talat Ahmed

³Houston Neonatal-Perinatal Medicine, Bellaire, Texas

,

Aideen M. Moore

⁴Division of Neonatology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada

⁵Department of Pediatrics, The University of Toronto, Toronto, Ontario, Canada

› Author Affiliations

Abstract

Objective To describe the circulating levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and IL-8 in stable premature infants, infants with suspect necrotizing enterocolitis (NEC)/feeding intolerance (FI), and infants with proven NEC and to determine whether combinations of markers could provide a diagnostic tool for differentiating between benign FI and NEC.

Methods Seventy infants were enrolled in a prospective study performed in two university neonatal intensive care units. Thirty-five matched controls (CON), 23 infants with FI or suspect NEC, and 12 infants with definitive and surgical NEC were studied. The pro-inflammatory cytokine (TNF-α, IL-6, and IL-8) levels were measured at the onset of FI or NEC, or during week 2 to 3 for CON.

Results There was no statistically significant difference in TNF-α levels among the three patient groups. IL-6 and IL-8 were significantly elevated in NEC group as compared with CON (p > 0.001), and in NEC group as compared with FI/suspect NEC. There was no significant difference in individual plasma levels of IL-6 or IL-8 between the CON and FI. The combined serum levels of IL-6 and IL-8 was more predictive of NEC stage II/III (area under the curve = 0.80; 95% confidence interval [CI]: 0.69–0.92; p < 0.0001).

Conclusion IL-6 and IL-8 were significantly elevated in infants with definitive surgical NEC but not those with FI. The combined level of IL-6 and IL-8 may be useful for distinguishing infants with suspect NEC/FI from those with NEC.

Keywords

necrotizing enterocolitis - neonatal intensive care unit - interleukin - tumor necrosis factor-α

Full Text

References

References
1 Li YF, Lin HC, Torrazza RM. , et al. Gastric residual evaluation in preterm neonates: a useful monitoring technique or a hindrance?. Pediatr Neonatol 2014; 55 (05) 335-340
2 Niknajad A, Ghojazadeh M, Sattarzadeh N, Bashar Hashemi F, Dezham Khoy Shahgholi F. Factors affecting the neonatal intensive care unit stay duration in very low birth weight premature infants. J Caring Sci 2012; 1 (02) 85-92
3 Brown KS, Gong H, Frey MR. , et al. Tumor necrosis factor induces developmental stage-dependent structural changes in the immature small intestine. Mediators Inflamm 2014; 2014: 852378 . Doi: 10.1155/2014/852378
4 Morag I, Goldman M, Kuint J, Heyman E. Excessive weight gain as a possible predictor of necrotizing enterocolitis in premature infants. Isr Med Assoc J 2007; 9 (01) 24-27
5 Neu J. Neonatal necrotizing enterocolitis: an update. Acta Paediatr Suppl 2005; 94 (449) 100-105
6 Neu J. Necrotizing enterocolitis: the mystery goes on. Neonatology 2014; 106 (04) 289-295
7 Dessi A, Pintus R, Marras S. , et al. Metabolomics in necrotizing enterocolitis: the state of the art. Expert Rev Mol Diagn 2016; 16 (10) 1053-1058
8 Young C, Sharma R, Handfield M, Mai V, Neu J. Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention?. Pediatr Res 2009; 65 (5 Pt 2): 91R-97R
9 Frost BL, Modi BP, Jaksic T, Caplan MS. New medical and surgical insights into neonatal necrotizing enterocolitis: a review. JAMA Pediatr 2017; 171 (01) 83-88
10 Claud EC, Savidge T, Walker WA. Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors. Pediatr Res 2003; 53 (03) 419-425
11 Frost BL, Jilling T, Caplan MS. The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis. Semin Perinatol 2008; 32 (02) 100-106
12 Markel TA, Crisostomo PR, Wairiuko GM. , et al. Cytokines in necrotizing enterocolitis. Shock 2006; 25 (04) 329-337
13 Morecroft JA, Spitz L, Hamilton PA, Holmes SJ. Plasma cytokine levels in necrotizing enterocolitis. Acta Paediatr Suppl 1994; 396: 18-20
14 Benkoe TM, Mechtler TP, Weninger M. , et al. Serum levels of interleukin-8 and gut-associated biomarkers in diagnosing necrotizing enterocolitis in preterm infants. J Pediatr Surg 2014; 49 (10) 1446-1451
15 Cheng S, Yu J, Zhou M, Tu Y, Lu Q. Serologic intestinal-fatty acid binding protein in necrotizing enterocolitis diagnosis: a meta-analysis. BioMed Res Int 2015; 2015: 156704 . Doi: 10.1155/2015/156704
16 Markel TA, Engelstad H, Poindexter BB. Predicting disease severity of necrotizing enterocolitis: how to identify infants for future novel therapies. J Clin Neonatol 2014; 3 (01) 1-9
17 Benkoe T, Baumann S, Weninger M. , et al. Comprehensive evaluation of 11 cytokines in premature infants with surgical necrotizing enterocolitis. PLoS One 2013; 8 (03) e58720 . Doi: 10.1371/journal.pone.0058720
18 Benkoe T, Reck C, Gleiss A. , et al. Interleukin 8 correlates with intestinal involvement in surgically treated infants with necrotizing enterocolitis. J Pediatr Surg 2012; 47 (08) 1548-1554
19 Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999; 103 (4 Pt 1): 766-771
20 Edelson MB, Sonnino RE, Bagwell CE. , et al. Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study. J Pediatr Surg 1999; 34 (10) 1453-1457
21 Benkoe T, Reck C, Pones M. , et al. Interleukin-8 predicts 60-day mortality in premature infants with necrotizing enterocolitis. J Pediatr Surg 2014; 49 (03) 385-389
22 Maheshwari A, Schelonka RL, Dimmitt RA. , et al. Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infants. Pediatr Res 2014; 76 (01) 100-108
23 Nelson KB, Grether JK, Dambrosia JM. , et al. Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res 2003; 53 (04) 600-607
24 Schulzke SM, Deshpande GC, Patole SK. Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies. Arch Pediatr Adolesc Med 2007; 161 (06) 583-590
25 Shalak LF, Perlman JM. Infection markers and early signs of neonatal encephalopathy in the term infant. Ment Retard Dev Disabil Res Rev 2002; 8 (01) 14-19
26 Carlos MA, Babyn PS, Marcon MA, Moore AM. Changes in gastric emptying in early postnatal life. J Pediatr 1997; 130 (06) 931-937
27 Bell MJ, Ternberg JL, Feigin RD. , et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187 (01) 1-7
28 Berthier F, Lambert C, Genin C, Bienvenu J. Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system. Clin Chem Lab Med 1999; 37 (05) 593-599
29 Hsueh W, Caplan MS, Qu XW. , et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003; 6 (01) 6-23
30 Hintz SR, Kendrick DE, Stoll BJ. , et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005; 115 (03) 696-703
31 Lodha A, Asztalos E, Moore AM. Cytokine levels in neonatal necrotizing enterocolitis and long-term growth and neurodevelopment. Acta Paediatr 2010; 99 (03) 338-343
32 Ren Y, Lin CL, Li Z. , et al. Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis. Histopathology 2005; 46 (06) 659-667
33 Buck C, Bundschu J, Gallati H, Bartmann P, Pohlandt F. Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics 1994; 93 (01) 54-58
34 Romagnoli C, Frezza S, Cingolani A. , et al. Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr 2001; 160 (06) 345-350
35 Harris MC, D'Angio CT, Gallagher PR. , et al. Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. J Pediatr 2005; 147 (04) 462-468
36 Harris MC, Costarino Jr AT, Sullivan JS. , et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 1994; 124 (01) 105-111
37 Halpern MD, Clark JA, Saunders TA. , et al. Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2006; 290 (04) G757-G764
38 McElroy SJ, Prince LS, Weitkamp JH. , et al. Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2011; 301 (04) G656-G666
39 Thuijls G, Derikx JP, van Wijck K. , et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010; 251 (06) 1174-1180
40 Chaaban H, Shin M, Sirya E. , et al. Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis. J Pediatr 2010; 157 (05) 757-761
41 Evennett N, Alexander N, Petrov M, Pierro A, Eaton S. A systematic review of serologic tests in the diagnosis of necrotizing enterocolitis. J Pediatr Surg 2009; 44 (11) 2192-2201
42 Epelman M, Daneman A, Navarro OM. , et al. Necrotizing enterocolitis: review of state-of-the-art imaging findings with pathologic correlation. Radiographics 2007; 27 (02) 285-305
43 Ng PC, Ma TP, Lam HS. The use of laboratory biomarkers for surveillance, diagnosis and prediction of clinical outcomes in neonatal sepsis and necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2015; 100 (05) F448-F452
44 Sylvester KG, Ling XB, Liu GY. , et al. Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr 2014; 164 (03) 607-12.e1 , 7
45 Murgas Torrazza R, Li N, Young C. , et al. Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants. Neonatology 2013; 104 (03) 234-242
46 Brook I. Microbiology and management of neonatal necrotizing enterocolitis. Am J Perinatol 2008; 25 (02) 111-118
47 Mshvildadze M, Neu J, Shuster J. , et al. Intestinal microbial ecology in premature infants assessed with non-culture-based techniques. J Pediatr 2010; 156 (01) 20-25
48 Wang Y, Hoenig JD, Malin KJ. , et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009; 3 (08) 944-954
49 Lin HC, Hsu CH, Chen HL. , et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008; 122 (04) 693-700